Skip to content

Transplantation of Autologous RPE Versus Translocation of Autologous RPE and Choroid in AMD

Transplantation of Autologous RPE Versus Translocation of Autologous RPE and Choroid in AMD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00401713
Enrollment
40
Registered
2006-11-20
Start date
2004-02-29
Completion date
2008-09-30
Last updated
2008-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-Related Macular Degeneration

Keywords

submacular membrane, transplantation of RPE, translocation of RPE and Choroid

Brief summary

The purpose of this study is to evaluate two surgical interventions in patients with AMD.

Detailed description

The Submacular surgical trials have shown that submacular membrane extraction alone did not improve or preserve visual acuity in patients with AMD. Transplantation of autologous RPE and translocation of autologous RPE and choroid represent two promising therapeutic interventions in patients with AMD. This prospective, randomized clinical trial compares the two surgical treatments and additionally compares the clinical results (visual acuity, FLA) with OCT- and UHR-OCT data.

Interventions

PROCEDURETransplantation of autologous RPE

RPE cell suspension

PROCEDURETranslocation of autologous RPE and Choroid

RPE patch

Sponsors

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* AMD and submacular cnv * non responders to laser treatment or pdt * treatment: rpe transplantation or rpe + choroid translocation * age over 50 years

Exclusion criteria

* other additional retinal diseases, like diabetic or hypertensive retinopathy and vascular diseases. * optic atrophy * unstable glaucoma

Design outcomes

Primary

MeasureTime frame
Visual Acuity: distance and nearpreoperatively, 1 months, 3 months, 12 months, +/- 18 months, 36 months
FLA(preoperatively, 3 months, +/- 12 months after surgery)

Secondary

MeasureTime frame
OCT(preoperatively, 3 months, 12 months after surgery)
UHR OCT(after surgery, including silicone oil removal)
autofluorescence(preoperatively, 3 months, +/- 12 months after surgery)
perimetry(if feasible)

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026